aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis [PDF]
Hepatocellular carcinoma (HCC) is the leading cause of death in patients with chronic hepatitis. In this international collaboration, we sought to develop a global universal HCC risk score to predict the HCC development for patients with chronic hepatitis.A total of 17,374 patients, comprising 10,578 treated Asian patients with chronic hepatitis B (CHB)
Rong Fan +2 more
exaly +12 more sources
Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study. [PDF]
Background and aimsChronic hepatitis B virus (HBV) infection remains a major global health burden and a leading cause of hepatocellular carcinoma (HCC).
Chanavee Toh +6 more
doaj +3 more sources
Prediction of Hepatocellular Carcinoma in a Portuguese Population after Hepatitis C Cure: Comparative Accuracy of Noninvasive Tests (Transient Elastography, FIB-4, and aMAP) [PDF]
Introduction: Chronic infection with hepatitis C virus (HCV) causes 25% of hepatocellular carcinoma (HCC) cases worldwide, a major cause of morbimortality even after sustained virologic response (SVR).
André Mascarenhas +26 more
doaj +3 more sources
AbstractBackground and AimsThe aMAP score was recently devised to predict hepatocellular carcinoma (HCC) development. However, its performance was not tested in alcohol‐related cirrhosis (ALC). We aimed to validate the aMAP score in a cohort of ALC patients.MethodStudy participants with ALC from a prior genome‐wide association study were included.
Ken Liu +8 more
openaire +3 more sources
IDDF2021-ABS-0137 The aMAP score predicts risk of hepatocellular carcinoma development in patients with alcohol-related cirrhosis [PDF]
Background The aMAP score (derived from age, male sex, albumin and platelet count) was recently devised to predict hepatocellular carcinoma (HCC) development. It was shown to have excellent performance irrespective of aetiology and ethnicity. Only one cohort of non-viral hepatitis patients (Japanese with mostly non-alcoholic fatty liver disease) was ...
Ken Liu +5 more
openaire +2 more sources
Approximately 62–72 million people are infected worldwide with HDV. Patients with chronic hepatitis D (CHD) have a higher risk of developing cirrhosis or hepatocellular carcinoma (HCC) and an increased mortality rate compared to those with chronic ...
Laura Iulia Grecu +8 more
doaj +2 more sources
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection [PDF]
Background & Aims: Hepatocellular carcinoma (HCC) prediction models can inform clinical decisions about HCC screening provided their predictions are robust. We conducted an external validation of 6 HCC prediction models for UK patients with cirrhosis
Hamish Innes +18 more
doaj +2 more sources
Yi Yang, 1,* Yanzhao Zhou, 2, 3,* Xinyuan Zhang, 1,* Yujing Xin, 1 Yi Chen, 1, 4 Qingsheng Fan, 5 Xiao Li, 1 Xi Wei, 6 Qiang Li, 3 Xiang Zhou, 1 Jinxue Zhou 2 1Department of Interventional Therapy, National Cancer Center/National Clinical Research ...
Yang Y +10 more
doaj +4 more sources
A report that reviews Arctic contaminants that are not currently regulated as persistent organic pollutants (POPs) under international treaties was recently published by the Arctic Monitoring and Assessment Programme (AMAP).
Efstathios Reppas-Chrysovitsinos +2 more
doaj +2 more sources
HCC risk stratification scores: insights from large multi-center national cohort study [PDF]
Current guidelines advocate biannual HCC surveillance for chronic hepatitis C patients who achieved sustained virological response (SVR) following direct acting antivirals (DAAs), posing a heavy burden on healthcare systems.
Imam Waked +11 more
doaj +2 more sources

